Viewing Study NCT03029858


Ignite Creation Date: 2025-12-25 @ 12:26 AM
Ignite Modification Date: 2026-03-03 @ 6:47 PM
Study NCT ID: NCT03029858
Status: UNKNOWN
Last Update Posted: 2017-01-24
First Post: 2017-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PD-L1 and Other Immuno-markers Influenced by Osimertinib Treatment in Advanced NSCLC Patients
Sponsor: Guangdong Association of Clinical Trials
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module